Please login to the form below
referendum
This page shows the latest referendum news and features for those working in and with pharma, biotech and healthcare.
Brexit nears as Conservatives sweep to victory in election
Labour’s decision to back a second referendum didn’t go down well with Leave-voting constituents in its Northern and Midlands heartlands, which swung firmly to the Tories. ... The Scottish National Party (SNP) ended the night with a massive majority
Latest news
-
Thousands of EU staffers have left NHS since 2016, says Lib Dems
Figures come from information provided by 50 NHS hospital trusts. Around 11, 600 workers from EU countries – including 4, 783 nurses – have left the NHS since the Brexit referendum, according to
-
Another day, another Brexit delay – so what happens now?
Former PM Tony Blair has suggested a simultaneous general election and a second referendum, saying there is nothing to stop both being organised at the same time.
-
Pharma frustration mounts as Johnson toys with no-deal Brexit pronouncements
members frustrated by the lack of progress since the referendum three years ago.
-
Threat of no-deal damaging life sciences, says UK biotech leader
This leaves just 100 days for the new prime minister to agree a Brexit deal, or otherwise face no-deal, or a potential general election or second referendum to break the
-
UK pharma’s hard-to-recruit posts need foreign recruitment boost
Fears about a strict post-Brexit immigration policy have been hampering life science recruitment (as well as many other sectors) since the referendum result three years ago, and show no sign
More from news
Approximately 0 fully matching, plus 50 partially matching documents found.
Latest Intelligence
-
Pharmaceutical social media after Cambridge Analytica
But the story began years before most people had heard of Cambridge Analytica, the data analytics company that has been associated with the Leave campaign for Britain’s EU membership referendum ... Evidence presented to the House of Commons Committee
-
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
Among the concrete actions taken since the Brexit referendum nearly three years ago is the creation of the UK Life Science Sector Deal.
-
The case for a second Brexit referendum: “We need the informed consent of the people”
Dr Phillip Lee MP is fighting to keep the UK in the EMA network - and for a second referendum. ... Since the summer some polls have consistently shown a narrow majority now opposed to Brexit and favouring a second referendum.
-
Leave or remain? Winning the employee referendum
Too often, just when we think we’ve found our dream job, something somewhere changes and we end up at the polling booth of our own personal referendum, faced with the ... The employee referendum is not a once-in-a-generation opportunity – it’s a
-
30 Women Leaders in UK Healthcare (part 2)
Originally pro-Brexit, Wollaston swapped sides before the referendum, and has since become highly critical of the government’s approach to Brexit.
More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest appointments
-
Scottish cabinet reshuffle sees Alex Neil made health secretary
working with government strategy and constitution, where she will have responsibility for preparations towards Scotland's independence referendum.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Social Media and Health: the Cure or the Disease?
There is compelling evidence that Russia used online bots and state-sponsored troll factories to manipulate opinions(4) in the run-up to the US election and the EU referendum in
-
In the news: What will the UK’s recent general election result and ongoing Brexit negotiations mean for DfID funding for global health?
Its future has come under increasing scrutiny following the UK referendum result in favour of leaving the EU last year, and again in the wake of last month’s general election
-
Don't you forget about me...
As we saw during the US Presidential election (and the EU Referendum last year), they often get it wrong.
-
Biosimilars - the Brexit of the pharmaceutical industry?
Much like the EU referendum, they feature regularly in the news - with spectators waiting anxiously, in some cases eagerly, for a change that could alter the treatment landscape for several significant ... Britain's relationship with the EU will be
-
The healthcare market research themes for 2014
In the UK, we are looking at the implications of an independent Scotland following a referendum which will take place in September.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Biogen and Happify Health team up to create digital platform for MS patients
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Moderna to launch Innovation and Technology Center in the UK
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis
- In recognition of the Anniversary of Stonewall, Nucleus Global brings attention and awareness to persistent health care inequities experienced by LGBTQIA+
- The Evolving Role of the Sales Rep
- Measure your omnichannel maturity with our new tool
- Report: Omnichannel advice for the life science industry
- Gilead Sciences supports Kigali Declaration for neglected tropical diseases
- As the NHS turns 74, it launches its ‘biggest NHS Big Tea ever’ to raise funds
- Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Almirall shares positive topline results from atopic dermatitis trials
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Pfizer to buy 8.1% stake in Valneva in support of joint Lyme disease programme
- Research from Imperial College London shows single brain scan could diagnose Alzheimer’s disease
PMHub
Nucleus Global
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...
Latest intelligence
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
- Report: Omnichannel advice for the life science industry
- In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...
